{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:56:02Z","timestamp":1769835362200,"version":"3.49.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T00:00:00Z","timestamp":1724976000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s00415-024-12663-z","type":"journal-article","created":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T12:02:27Z","timestamp":1725019347000},"page":"7026-7029","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic ancillary examinations in clinical neurology"],"prefix":"10.1007","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3610-3437","authenticated-orcid":false,"given":"Rui","family":"Ara\u00fajo","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3027-5497","authenticated-orcid":false,"given":"Alastair J.","family":"Noyce","sequence":"additional","affiliation":[]},{"given":"Bastiaan R.","family":"Bloem","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,8,30]]},"reference":[{"issue":"12","key":"12663_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601","journal-title":"Mov Disord"},{"issue":"6","key":"12663_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1474-4422(21)00422-1","volume":"21","author":"M Hallett","year":"2022","unstructured":"Hallett M, Aybek S, Dworetzky BA, McWhirter L, Staab JP, Stone J (2022) Functional neurological disorder: new subtypes and shared mechanisms. Lancet Neurol 21(6):537\u2013550","journal-title":"Lancet Neurol"},{"issue":"8","key":"12663_CR3","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1136\/jnnp-2019-322676","volume":"91","author":"J van de Wardt","year":"2020","unstructured":"van de Wardt J, van der Stouwe AM, Dirkx M, Elting JWJ, Post B, Tijssen MA, Helmich RC (2020) Systematic clinical approach for diagnosing upper limb tremor. J Neurol Neurosurg Psychiatry 91(8):822\u2013830","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"12663_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1212\/WNL.0b013e31825fdf63","volume":"79","author":"J Stone","year":"2012","unstructured":"Stone J, Edwards M (2012) Trick or treat? Showing patients with functional (psychogenic) motor symptoms their physical signs. Neurology 79(3):282\u2013284","journal-title":"Neurology"},{"issue":"6","key":"12663_CR5","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/practneurol-2019-002339","volume":"19","author":"R Ara\u00fajo","year":"2019","unstructured":"Ara\u00fajo R, van Rumund A, Bloem BR (2019) To scan or not to scan your Parkinson patient: that is the question! Pract Neurol 19(6):462\u2013464","journal-title":"Pract Neurol"},{"issue":"10","key":"12663_CR6","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1212\/WNL.0b013e318248e520","volume":"78","author":"R de la Fuente-Fern\u00e1ndez","year":"2012","unstructured":"de la Fuente-Fern\u00e1ndez R (2012) Role of DaTSCAN and clinical diagnosis in Parkinson disease. Neurology 78(10):696\u2013701","journal-title":"Neurology"},{"issue":"908","key":"12663_CR7","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1259\/bjr\/89012738","volume":"76","author":"AC Lamont","year":"2003","unstructured":"Lamont AC, Alias NA, Win MN (2003) Red flags in patients presenting with headache: clinical indications for neuroimaging. Br J Radiol 76(908):532\u2013535","journal-title":"Br J Radiol"},{"key":"12663_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2019.00052","volume":"7","author":"A Micieli","year":"2019","unstructured":"Micieli A, Kingston W (2019) An approach to identifying headache patients that require neuroimaging. Front Public Health 7:421539","journal-title":"Front Public Health"},{"issue":"7","key":"12663_CR9","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1093\/neuonc\/noad012","volume":"25","author":"NR Smoll","year":"2023","unstructured":"Smoll NR, Brady Z, Scurrah KJ, Lee C, Berrington de Gonz\u00e1lez A, Mathews JD (2023) Computed tomography scan radiation and brain cancer incidence. Neuro Oncol 25(7):1368\u20131376","journal-title":"Neuro Oncol"},{"key":"12663_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116997","volume":"416","author":"J Kamtchum-Tatuene","year":"2020","unstructured":"Kamtchum-Tatuene J, Kenteu B, Fogang YF, Zafack JG, Nyaga UF, Noubiap JJ (2020) Neuroimaging findings in headache with normal neurologic examination: systematic review and meta-analysis. J Neurol Sci 416:116997","journal-title":"J Neurol Sci"},{"issue":"11","key":"12663_CR11","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1002\/mds.26712","volume":"31","author":"J Nonnekes","year":"2016","unstructured":"Nonnekes J, Timmer MH, de Vries NM, Rascol O, Helmich RC, Bloem BR (2016) Unmasking levodopa resistance in Parkinson\u2019s disease. Mov Disord 31(11):1602\u20131609","journal-title":"Mov Disord"},{"issue":"1","key":"12663_CR12","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41531-022-00321-y","volume":"8","author":"M Beckers","year":"2022","unstructured":"Beckers M, Bloem BR, Verbeek MM (2022) Mechanisms of peripheral levodopa resistance in Parkinson\u2019s disease. npj Parkinson\u2019s Dis 8(1):56","journal-title":"npj Parkinson's Dis"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12663-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12663-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12663-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T03:54:33Z","timestamp":1727927673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12663-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,30]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["12663"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12663-z","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,30]]},"assertion":[{"value":"9 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Prof Rui Ara\u00fajo received speaking fees from Bial. Prof Noyce reports grants from Parkinson's UK, Barts Charity, Cure Parkinson\u2019s, National Institute for Health and Care Research, Innovate UK, Virginia Keiley benefaction, Solvemed, the Medical College of Saint Bartholomew\u2019s Hospital Trust, Alchemab, Aligning Science Across Parkinson\u2019s Global Parkinson\u2019s Genetics Program (ASAP-GP2), and the Michael J Fox Foundation. Prof Noyce reports consultancy and personal fees from AstraZeneca, AbbVie, Profile, Bial, Charco Neurotech, Alchemab, Sosei Heptares, Umedeor, and Britannia. Prof Noyce has share options in Umedeor. Prof Noyce is an Associate Editor for the Journal of Parkinson\u2019s Disease. Outside the present work, Prof Bloem has the following to report. He is co-Editor-in-Chief for the Journal of Parkinson\u2019s disease. He is on the editorial board of Practical Neurology and Digital Biomarkers, has received honoraria from being on the scientific advisory board for Abbvie, Biogen, and UCB, has received fees for speaking at conferences from AbbVie, Zambon, Roche, GE Healthcare, and Bial, and has received research support from the Netherlands Organization for Scientific Research, the Michael J Fox Foundation, UCB, Not Impossible, the Hersenstichting Nederland, the Parkinson\u2019s Foundation, Verily Life Sciences, Horizon 2020, and the Parkinson Vereniging (all paid to the institute).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The authors confirm that the approval of an institutional review board was not required for this work. Also, patient consent was not required. We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this work is consistent with those guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standard"}}]}}